Learn More
Medchemexpress LLC Ripretinib | 1442472-39-0 | 98.7% | 510.36 | C24H21BrFN5O2 | 5 MG

Supplier: Medchemexpress LLC HY1123065MG
Ripretinib is a research-grade small-molecule kinase inhibitor that functions as a switch-control inhibitor of KIT and PDGFRA and displays activity against additional kinases. Supplied as a powdered reagent for laboratory research use only.
- Targets wild-type and mutant KIT and PDGFRA.
- Inhibits FLT3 and KDR/VEGFR-2.
- Demonstrated oral bioavailability in preclinical studies.
- High purity suitable for biochemical and cellular assays.
- Supplied as a powder for flexible formulation and dosing.
- Available in small research pack sizes for screening and pilot studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.